Broad anti-angiogenic activity

Assets acting on this target.

Class
PEGylated recombinant human endostatin (anti-angiogenic biologic; modality should be corrected from null to 'biologic/recombinant protein', not a small molecule)
Pathway
Tumor angiogenesis inhibition
Notes
original target text: Broad anti-angiogenic activity (endothelial cell proliferation; VEGF/bFGF signaling and integrin/heparan-sulfate proteoglycan binding), not a single discrete receptor target

Related mechanisms

← all mechanisms